Peer-Reviewed Gold Open Access | COPE & ICMJE Standards Adherent
Independent Academic Publishing

Advancing Global Research Through Ethical Open Access

ClaudeX Academic delivers rigorous double-blind peer review, permanent Crossref DOIs, and unrestricted global dissemination across clinical, medical, pediatric, and computational sciences.

Scholarly Publishing Standards

100% Gold Open Access Free to read and cite under CC BY 4.0
Double-Blind Peer Review Unbiased independent expert appraisal
21–28 Day Review Speed Rapid editorial decision without compromises
Crossref DOIs & Archiving Permanent digital object identifiers
Submit Your Manuscript
4 Peer-Reviewed Journals
7 Published Articles
8 Research Disciplines
7 Editorial Board Members
Publishing Mission

Bridging the Gap Between Research and Discovery

ClaudeX Academic is built upon the conviction that research breakthroughs should be immediately and unrestricted accessible to healthcare professionals, academic scholars, and communities worldwide. We dismantle paywalls and eliminate subscription barriers while maintaining uncompromising peer-review integrity.

COPE Adherence

Strict compliance with Committee on Publication Ethics core practices.

Author Rights

Authors retain 100% copyright ownership of their data and manuscripts.

Global Publishing Framework

  • Equitable Global Waivers: Automatic 100% fee waivers for authors affiliated with institutions in low-income economies.
  • Zero Tolerance for Plagiarism: Automated Crossref Similarity Check (iThenticate) screening on every single submission.
  • Independent Editorial Governance: Editors hold total decision-making independence completely uninfluenced by commercial factors.
Learn More About ClaudeX Academic →
Subject Classification

Browse Journals by Discipline

Discover scholarly literature across medical, clinical, and technological domains.

View All Categories →
Peer-Reviewed Titles

Featured Academic Journals

Flagship publications adhering to the highest standards of scholarship and transparency.

All Journals (4) →
ISSN: 2835-4923 Open Access

Cardiology and Cardiovascular Research

International open-access journal publishing cutting-edge peer-reviewed research across clinical cardiology, interventional procedures, heart failure, and cardiovascular therapies.

Quarterly Frequency
1 Articles
Double-Blind Review
ISSN: 2790-1122 Open Access

Advances in Health and Medicine

Clinical practice, diagnostics, and healthcare innovation across general and specialty medicine.

Monthly Frequency
3 Articles
Double-Blind Review
ISSN: 2790-1189 Open Access

Current Trends in Pediatrics & Child Health

Innovations in pediatric care, developmental health, and childhood disease prevention.

Quarterly Frequency
2 Articles
Double-Blind Review
ISSN: 2790-1250 Open Access

Journal of AI & Computational Medicine

Machine learning, computational modeling, and AI-driven diagnostics in healthcare.

Bi-monthly Frequency
1 Articles
Double-Blind Review
Scholarly Output

Recently Published Research

Latest peer-reviewed articles across all ClaudeX Academic journals.

Explore All Publications →
Original Research Gold Open Access DOI: 10.6001/cxa.2026.ip01

Prospective Multi-Center Evaluation of Novel Biomarkers in Early Diagnostic Stratification

Background: Timely clinical intervention hinges upon sensitive, early-stage biomarkers capable of discriminating distinct disease phenotypes. This multi-center prospective trial assesses the diagnostic sensitivity, specificity, and prognostic value of circulating molecular markers.\n\nMethods: Serum and plasma samples from 540 enrolled subjects were analyzed using high-throughput targeted proteomic assays and multiplex immunoassays.\n\nResults: The combined panel achieved an AUC of 0.94 (95% CI 0.91–0.97) for discriminating high-risk progression.\n\nConclusion: Incorporating this biomarker panel markedly enhances predictive stratifications, establishing an actionable framework for targeted therapeutic triage.

Published: Oct 10, 2026
Original Research Gold Open Access DOI: 10.6002/cxa.2026.ip01

Prospective Multi-Center Evaluation of Novel Biomarkers in Early Diagnostic Stratification

Background: Timely clinical intervention hinges upon sensitive, early-stage biomarkers capable of discriminating distinct disease phenotypes. This multi-center prospective trial assesses the diagnostic sensitivity, specificity, and prognostic value of circulating molecular markers.\n\nMethods: Serum and plasma samples from 540 enrolled subjects were analyzed using high-throughput targeted proteomic assays and multiplex immunoassays.\n\nResults: The combined panel achieved an AUC of 0.94 (95% CI 0.91–0.97) for discriminating high-risk progression.\n\nConclusion: Incorporating this biomarker panel markedly enhances predictive stratifications, establishing an actionable framework for targeted therapeutic triage.

Published: Oct 10, 2026
Original Research Gold Open Access DOI: 10.6003/cxa.2026.ip01

Prospective Multi-Center Evaluation of Novel Biomarkers in Early Diagnostic Stratification

Background: Timely clinical intervention hinges upon sensitive, early-stage biomarkers capable of discriminating distinct disease phenotypes. This multi-center prospective trial assesses the diagnostic sensitivity, specificity, and prognostic value of circulating molecular markers.\n\nMethods: Serum and plasma samples from 540 enrolled subjects were analyzed using high-throughput targeted proteomic assays and multiplex immunoassays.\n\nResults: The combined panel achieved an AUC of 0.94 (95% CI 0.91–0.97) for discriminating high-risk progression.\n\nConclusion: Incorporating this biomarker panel markedly enhances predictive stratifications, establishing an actionable framework for targeted therapeutic triage.

Published: Oct 10, 2026
Author Benefits

Why Publish With ClaudeX Academic

We prioritize author satisfaction, scientific integrity, and global reach at every step.

Rapid Turnaround Time

Initial editorial decision rendered within 21 to 28 days. Accepted manuscripts publish online in 5 days.

Rigorous Double-Blind Review

Completely unbiased peer review evaluated exclusively on methodological validity and scientific evidence.

Global Open Dissemination

Immediate worldwide visibility under CC BY 4.0 ensures clinicians and researchers anywhere can cite your paper.

Author Retains 100% Copyright

Never forfeit ownership of your data or intellectual property. You retain permanent copyright without restriction.

Transparent APCs & Full Waivers

Zero submission charges. 100% automatic waivers granted to authors from developing World Bank low-income nations.

Permanent Digital Archiving

Deposited in persistent international digital preservation networks to guarantee access in perpetuity.

Call for Submissions & Reviewers

Submit Your Manuscript or Join Our Editorial Community

We invite researchers worldwide to submit original papers or apply to serve on our international editorial boards and reviewer panels.

Press & Updates

Latest News & Announcements

Scholarly developments, editorial appointments, and publishing milestones.

View All News →
Research News Nov 19, 2026

ClaudeX Academic Crosses 2,000 Published Articles

A milestone in our publishing and research visibility journey across disciplines and regions.

Webinar Nov 02, 2026

Writing for Impact: A Workshop for First-Time Authors

A practical mentorship workshop focused on publishing, peer review, and manuscript preparation.

Conference Sep 14, 2026

Global Summit on Open Science & AI in Medicine

A landmark conference on open science, digital health, and AI in medicine.